Beijing, China — A Chinese pharmaceutical company said Wednesday it had agreed to buy at least 100 million doses of the coronavirus vaccine from German company BioNTech, subject to Beijing approving its use.
China has been rapidly developing its own COVID-19 vaccine candidates and ramping up production facilities, but local firms have also been partnering with foreign developers to supply the world’s most populous country.
Shanghai Fosun Pharmaceutical Group said its subsidiary had entered into an agreement with the German firm aimed at ensuring “an adequate supply” of vaccines in China, adding it will make an initial payment of 125 million euros ($152 million) before year-end fo…
Keep on reading: China’s Fosun Pharma to import 100 million BioNTech vaccine doses